Table of Contents
<< Previous Issue | Oct 2003 (Vol: 2003, Issue: 40) | Next Issue >> |
- Section: Company Profile
-
Acambis plc
-
Genestream Pty Ltd
- Section: General
-
Medivir and Boehringer Ingelheim in HIV Deal
-
The problem with Antibiotics
-
Therapy Focus: Severe Acute Respiratory Syndrome
- Section: Licensing
-
Aventis and Regeneron Enter Collaboration for VEGF Trap
-
Bristol-Myers Squibb Licenses Flamel’s Basulin®
-
Amgen Enters metabolic Disease Market with Biovitrum Deal
- Section: Mergers & Acquisitions
-
Xenova Acquires KS Biomedix to Focus on Brain Cancer Drug
- Section: Research & Development
-
Merck Backs Alnylam’s RNAi Technology